Al Mansour Pharmaceuticals Industries Co operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Al Mansour Pharmaceuticals Industries Co with three other
pharmaceutical manufacturers in Middle East:
Sabaa International Company for Pharmaceutical & Chemical Industries SAE
sales of 69.76 million Egyptian Pounds [US$4.45 million]
Purple Biotech Ltd
(3.42 million Israel Shekels [US$1.05 million]
of which 100%
was Pain and Hypertension), and
Alexandria Company for Pharmaceuticals and Chemical Industries SAE
based in EGYPT
(1.02 billion Egyptian Pounds [US$65.36 million]
Sales levels dropped significantly in the first
quarter of 2021 versus the previous year's first quarter.
During the first
quarter of 2021, sales at Al Mansour Pharmaceuticals Industries Co totalled
34.65 million Iraqi Dinar.
This is a drop of 86.5%
from the 256.35 million Iraqi Dinar in sales at the company during the first quarter in 2020.
Al Mansour Pharmaceuticals Industries Co reported sales of 873.50 million Iraqi Dinar
December of 2020.
increase of 91.0%
versus 2019, when the company's sales were 457.35 million Iraqi Dinar.
Despite this increase, sales are still
below the level achieved in 2018, when Al Mansour Pharmaceuticals Industries Co
reported sales of 1.91 billion Iraqi Dinar.